NCT00171236View on ClinicalTrials.gov

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Heterozygous Familial HypercholesterolemiaMixed Dyslipidemia
Interventions
DRUG

Fluvastatin

Trial Locations (1)

Unknown

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY